Zinzino AB’s business operations began in the fall of 2007. The principal activity of the company is owing and developing companies within direct marketing and related business activities.
In 2009, Zinzino Nordic AB was partly acquired through a directed share issue to shareholders in Zinzino Nordic AB and partly through a subscription of shares, in the preferential rights issue, Zinzino Nordic AB carried out, in December 2009. This gave Zinzino AB control over 97% of the votes and 92% of the capital in Zinzino Nordic AB. As of December 31, 2014, ownership had
increased to 93% of the capital.
Since December 11, 2014, Zinzino AB has been listed on Nasdaq OMX First North.
Share performance has been very positive, especially over the past two years.
In 2011, the Group extended to include companies in Estonia and Lithuania. In 2012, companies were also launched in Latvia and Iceland. In 2013, a company was started in the USA, with its headquarters in Jupiter, Florida. Unlike the previous Group structure, the new subsidiaries are directly owned by Zinzino AB.
In 2014, companies were established in Poland and the Netherlands.
In 2014, Zinzino AB acquired the remaining shares in BioActive Foods AS and 85% of the shares in Faun Pharma AS.
A company was started in Canada, in 2015.